PLx Pharma has appointed Michael J. Valentino as Chairman of its Board of Directors.
Mr Valentino has previously worked for Adams Respiratory Therapeutics, Novartis AG and Warner Lambert.
Ron Zimmerman, President and CEO of PLx Pharma, said: “Mike’s exceptional industry and commercialisation experience with a range of OTC and Rx drug products will be extremely valuable”.
PLx is a pharmaceutical company developing gastrointestinal (GI) safer formulations of proven non-steroidal anti-inflammatory drugs (NSAIDs) including aspirin, ibuprofen and indomethacin for over-the-counter and prescription markets.
